Table 1.
Independent risk factors for incidence of COVID-19 in all HD patients
Independent risk factors for COVID-19 | OR (95% CI) | P-value |
---|---|---|
Age (≥70 years) | 0.79 (0.6–0.98) | 0.045 |
Sex (male) | 0.88 (0.7–1.1) | 0.272 |
BMI | 1.15 (1.01–1.31) | 0.035 |
Diabetes mellitus | 1.25 (0.97–1.61) | 0.083 |
Vitamin D supplementation | 0.96 (0.76–1.21) | 0.707 |
Hemoglobin | 0.95 (0.85–1.05) | 0.285 |
Albumin | 0.96 (0.93–1) | 0.032 |
Inorganic phosphorus | 1.04 (0.96–1.12) | 0.330 |
Calcium | 0.93 (0.8–1.09) | 0.385 |
Intact PTH | 0.96 (0.79–1.17) | 0.682 |
Living in a nursing home | 2.94 (1.52–5.71) | 0.001 |
Education—primary school | 1.67 (0.48–0.93) | 0.017 |
Glomerulonephritis | 1.15 (0.84–1.57) | 0.396 |
Weight gain | 1.03 (0.95–1.11) | 0.540 |
Cardiovascular disease | 1.04 (0.81–1.33) | 0.773 |
Gastrointestinal diseases | 1.08 (0.83–1.41) | 0.579 |
Mental and behavioural disorders | 1.3 (0.9–1.88) | 0.163 |
HIV infection | 1.39 (0.19–10.2) | 0.743 |
Parathyroidectomy | 0.55 (0.28–1.09) | 0.085 |
ARBs | 0.72 (0.53–0.99) | 0.092 |
ACE inhibitors | 1.18 (0.89–1.56) | 0.262 |
Nitrates | 1.1 (0.79–1.53) | 0.579 |
Antidepressants | 1.11 (0.7–1.75) | 0.664 |
Phosphate binders | 1.09 (0.86–1.39) | 0.479 |
Calcimimetics | 1.04 (0.72–1.5) | 0.828 |
Fibrates | 1.24 (0.65–2.37) | 0.515 |
Oral anticoagulants | 1.41 (0.98–2.03) | 0.061 |
Statins | 1.13 (0.88–1.46) | 0.338 |
Acetylic salicylic acid | 1.18 (0.93–1.49) | 0.178 |
ORs were calculated by logistic regression models, adjusted for all variables with a P < 0.2 in the univariate analyse, country and the following variables, considered to be of clinical relevance for the predicted outcomes: age, gender, BMI, diabetes mellitus, treatment with active vitamin D, hemoglobin, serum inorganic phosphorus, calcium and intact PTH. HIV, human immunodeficiency virus.